Global Information
회사소개 | 문의 | 비교리스트

원료 의약품(API) 시장 : 규모, 점유율, 전망, 기회 분석(2017-2025년)

Active Pharmaceutical Ingredients Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

리서치사 Coherent Market Insights
발행일 2019년 04월 상품 코드 833141
페이지 정보 영문
가격
US $ 4,500 ₩ 5,431,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 8,449,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 12,070,000 PPT Turned PDF (Enterprise User License)


원료 의약품(API) 시장 : 규모, 점유율, 전망, 기회 분석(2017-2025년) Active Pharmaceutical Ingredients Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025
발행일 : 2019년 04월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

원료 의약품(API)은 의약품 제조에 사용되는 활성 성분이며, 신체에 약리학적/치료적 효과를 제공합니다. API는 미가공 형태로는 사용할 수 없으므로 약리학적/치료학으로 비활성인 적절한 부형제와 결합되어 안정성과 활동을 증강시킵니다.

세계의 원료 의약품(API: Active Pharmaceutical Ingredients) 시장을 조사했으며, 시장 개요, 종류 및 지역별 시장 동향, 시장 규모 추이와 예측, 시장 성장 촉진요인 및 저해요인, 시장 기회 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 조사 목적과 전제조건

  • 조사 목적
  • 전제조건
  • 약어

제2장 시장 범위

  • 보고서에 대해
    • 시장 정의와 범위
  • 주요 요약
    • API별 시장
    • 합성 유형별 시장
    • 용도별 시장
    • 지역별 시장
  • Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 성장 촉진요인
    • 성장 저해요인
    • 시장 기회
  • 영향 해석
  • 시장 동향
  • PEST 분석
  • 인수합병(M&A)
  • API 특허의 유효기간
  • 규제 시나리오
  • 파이프라인 분석

제4장 API별 시장, 2018-2026년(10억 달러)

  • 서론
  • 선발 의약품/혁신적 의약품
  • 제네릭 의약품

제5장 합성 유형별 시장, 2018-2026년(10억 달러)

  • 서론
  • 합성
  • 바이오태크

제6장 용도별 시장, 2018-2026년(10억 달러)

  • 서론
  • 당뇨병
  • 종양학
  • 심장혈관
  • CNS
  • 진통제
  • 기타

제7장 지역별 시장, 2018-2026년(10억 달러)

  • 서론
  • 북미
  • 중남미
  • 유럽
  • 아시아태평양
  • 중동
  • 아프리카

제8장 경쟁 구도

  • 히트 맵 분석
  • 시장 점유율 분석
  • 기업 개요
    • Teva Pharmaceutical Industries Ltd.
      • API 포트폴리오
    • Pfizer, Inc.
    • BASF SE
    • Dr. Reddy's Laboratories Ltd
    • Novartis AG
    • Mylan N.V.
    • Sanofi S.A.
    • Lonza
  • 애널리스트의 의견

제9장 섹션

  • 참고 문헌
  • 조사 방법
  • Coherent Market Insights에 대해
LSH 19.05.20

Active Pharmaceutical Ingredients (API) are active constituents used in the manufacturing of pharmaceutical formulations and have pharmacological and therapeutic effects on the body. Since APIs cannot be used in the raw form, they are combined with the suitable excipients, which are pharmacologically and therapeutically inactive but enhance its stability and activities.

Market Dynamics

Increasing prevalence of chronic diseases, geographical expansion of active pharmaceutical ingredient manufacturers in Asia, and increasing investment in research and development by manufacturers are some of the major factors that are expected to drive the market growth. Furthermore, increasing production of generic drugs is in turn driving growth of global active pharmaceutical ingredients market. For instance, according to the Indian Brand Equity Foundation (IBEF), in 2018, India was the largest producer of generic medicines, which supplied 50% of vaccines and 40% of drugs to the U.S. and 25% of drugs to the U.K. However, unfavorable drug price control policies across various countries is expected to negatively affect growth of the market.

Key features of the study:

  • This report provides in-depth analysis of the active pharmaceutical ingredients market and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global active pharmaceutical ingredients market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Pfizer, Inc., BASF SE, Dr. Reddy's Laboratories Ltd., Novartis AG, Mylan N.V., Sanofi S.A., and Lonza
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global active pharmaceutical ingredients market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the active pharmaceutical ingredients market

Detailed Segmentation:

  • Global Active Pharmaceutical Ingredients Market, By API:
    • Branded/ Innovative
    • Generic
  • Global Active Pharmaceutical Ingredients Market, By Type of Synthesis:
    • Synthetic
    • Biotech
  • Global Active Pharmaceutical Ingredients Market, By Application:
    • Diabetes
    • Oncology
    • Cardiovascular
    • CNS
    • Analgesics
    • Others
  • Global Active Pharmaceutical Ingredients Market, By Region:
    • North America
      • By API:
      • Branded/ Innovative
      • Generic
      • By Type of Synthesis:
      • Synthetic
      • Biotech
      • By Application:
      • Diabetes
      • Oncology
      • Cardiovascular
      • CNS
      • Analgesics
      • Others
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By API:
      • Branded/ Innovative
      • Generic
      • By Type of Synthesis:
      • Synthetic
      • Biotech
      • By Application:
      • Diabetes
      • Oncology
      • Cardiovascular
      • CNS
      • Analgesics
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By API:
      • Branded/ Innovative
      • Generic
      • By Type of Synthesis:
      • Synthetic
      • Biotech
      • By Application:
      • Diabetes
      • Oncology
      • Cardiovascular
      • CNS
      • Analgesics
      • Others
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By API:
      • Branded/ Innovative
      • Generic
      • By Type of Synthesis:
      • Synthetic
      • Biotech
      • By Application:
      • Diabetes
      • Oncology
      • Cardiovascular
      • CNS
      • Analgesics
      • Others
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By API:
      • Branded/ Innovative
      • Generic
      • By Type of Synthesis:
      • Synthetic
      • Biotech
      • By Application:
      • Diabetes
      • Oncology
      • Cardiovascular
      • CNS
      • Analgesics
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By API:
      • Branded/ Innovative
      • Generic
      • By Type of Synthesis:
      • Synthetic
      • Biotech
      • By Application:
      • Diabetes
      • Oncology
      • Cardiovascular
      • CNS
      • Analgesics
      • Others
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Teva Pharmaceutical Industries Ltd.*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Pfizer, Inc.
    • BASF SE
    • Dr. Reddy's Laboratories Ltd.
    • Novartis AG
    • Mylan N.V.
    • Sanofi S.A.
    • Lonza

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By API
    • Market Snippet, By Type of Synthesis
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • PEST Analysis
  • Mergers and Acquisitions
  • API Patent Expiration
  • Regulatory Scenario
  • Pipeline Analysis

4. Global Active Pharmaceutical Ingredients Market, By API, 2018 - 2026, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2016 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Branded/ Innovative
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
  • Generic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)

5. Global Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2026, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2016 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Synthetic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
  • Biotech
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)

6. Global Active Pharmaceutical Ingredients Market, By Application, 2018 - 2026, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2016 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
  • CNS
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
  • Analgesics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)

7. Global Active Pharmaceutical Ingredients Market, By Region, 2018 - 2026, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2016 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By API, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Type of Synthesis, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Bn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By API, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Type of Synthesis, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By API, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Type of Synthesis, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Bn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By API, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Type of Synthesis, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By API, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Type of Synthesis, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By API, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Type of Synthesis, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Bn)
    • Market Size and Forecast, By Country/Region, 2016 - 2026, (US$ Bn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profiles
    • Teva Pharmaceutical Industries Ltd.*
    • Company Overview
    • API Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer, Inc.
    • Company Overview
    • API Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • BASF SE
    • Company Overview
    • API Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Dr. Reddy's Laboratories Ltd
    • Company Overview
    • API Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novartis AG
    • Company Overview
    • API Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Mylan N.V.
    • Company Overview
    • API Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi S.A.
    • Company Overview
    • API Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Lonza
    • Company Overview
    • API Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top
전화 문의
F A Q